|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
CA2026147C
(en)
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
|
DK0672142T3
(da)
|
1992-12-04 |
2001-06-18 |
Medical Res Council |
Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse
|
|
ES2162863T3
(es)
|
1993-04-29 |
2002-01-16 |
Unilever Nv |
Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
AU751659B2
(en)
|
1997-05-02 |
2002-08-22 |
Genentech Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6924141B2
(en)
|
2000-03-31 |
2005-08-02 |
The General Hospital Corporation |
Methods of modulating hair growth
|
|
US7713526B2
(en)
|
2001-05-01 |
2010-05-11 |
The Regents Of The University Of California |
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
|
|
US20030044409A1
(en)
|
2001-05-01 |
2003-03-06 |
Carson Dennis A. |
Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US8093357B2
(en)
|
2002-03-01 |
2012-01-10 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
AU2003250074B2
(en)
|
2002-07-18 |
2010-09-09 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
US8367822B2
(en)
|
2003-09-22 |
2013-02-05 |
Enzo Therapeutics, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US9046537B2
(en)
|
2003-09-22 |
2015-06-02 |
Enzo Biochem, Inc. |
Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
|
|
US8637506B2
(en)
|
2003-09-22 |
2014-01-28 |
Enzo Biochem, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US8461155B2
(en)
|
2003-09-22 |
2013-06-11 |
University Of Connecticut |
Sclerostin and the inhibition of WNT signaling and bone formation
|
|
WO2005032574A1
(en)
|
2003-10-03 |
2005-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway
|
|
AU2004297616B2
(en)
|
2003-12-04 |
2008-12-18 |
Xencor, Inc. |
Methods of generating variant proteins with increased host string content and compositions thereof
|
|
EP1716181B1
(en)
|
2004-02-19 |
2009-12-16 |
Genentech, Inc. |
Cdr-repaired antibodies
|
|
CA2566607C
(en)
|
2004-05-13 |
2014-04-15 |
University Of Virginia Patent Foundation |
Use of lacritin in promoting ocular cell survival
|
|
US9052324B2
(en)
|
2004-05-19 |
2015-06-09 |
Enzo Biochem, Inc. |
Compounds and assays for controlling Wnt activity
|
|
US8343922B2
(en)
|
2004-05-19 |
2013-01-01 |
Enzo Biochem, Inc. |
Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
|
|
CN101001873B
(zh)
|
2004-08-04 |
2013-03-13 |
曼璀克生物科技有限责任公司 |
Fc区变体
|
|
AU2005267722B2
(en)
|
2004-08-04 |
2009-10-08 |
Amgen Inc. |
Antibodies to Dkk-1
|
|
DE102004050620A1
(de)
|
2004-10-13 |
2006-04-20 |
Eberhard-Karls-Universität Tübingen |
Monoklonaler Antikörper gegen Frizzled-Rezeptoren
|
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
|
CA2587766A1
(en)
|
2004-11-10 |
2007-03-01 |
Macrogenics, Inc. |
Engineering fc antibody regions to confer effector function
|
|
WO2006079372A1
(en)
|
2005-01-31 |
2006-08-03 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
|
AU2006230413B8
(en)
|
2005-03-31 |
2011-01-20 |
Xencor, Inc |
Fc variants with optimized properties
|
|
US7771937B2
(en)
|
2005-05-20 |
2010-08-10 |
University Of Washington |
Methods for predicting late onset Alzheimer disease in an individual
|
|
US20090311243A1
(en)
|
2005-05-30 |
2009-12-17 |
Astrazeneca Ab |
Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
|
|
DE102005035568A1
(de)
|
2005-07-25 |
2007-02-01 |
M-Phasys Gmbh |
Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns
|
|
US10155816B2
(en)
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
CA2635906A1
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
Materials and methods for identifying agents that modulate norrin. norrin mimetics, and agents identified thereby
|
|
EP2418223A3
(en)
|
2006-06-12 |
2013-01-16 |
Emergent Product Development Seattle, LLC |
Single-chain multivalent binding proteins with effector function
|
|
CA2655289C
(en)
|
2006-06-21 |
2016-08-23 |
Oncotherapy Science, Inc. |
Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
EP2104682B1
(en)
*
|
2007-01-11 |
2016-09-21 |
Michael Bacher |
Diagnosis and treatment of alzheimer's and other neurodementing diseases
|
|
US20100199362A1
(en)
|
2007-04-26 |
2010-08-05 |
President And Fellows Of Harvard College |
Wnt ligands involved in blood-brain barrier development and uses therefor
|
|
EP2567709B1
(en)
|
2007-11-02 |
2017-12-27 |
Novartis AG |
Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
|
|
US8715941B2
(en)
|
2007-11-16 |
2014-05-06 |
Arca Biopharma, Inc. |
Antibodies to LRP6
|
|
US9266967B2
(en)
|
2007-12-21 |
2016-02-23 |
Hoffmann-La Roche, Inc. |
Bivalent, bispecific antibodies
|
|
EP2274010A1
(en)
|
2008-04-11 |
2011-01-19 |
Biogen Idec MA Inc. |
Therapeutic combinations of anti-igf-1r antibodies and other compounds
|
|
WO2010016766A2
(en)
|
2008-08-08 |
2010-02-11 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Antibodies recognizing endogenous human lgr5 and/or lgr6
|
|
NO2321351T3
(enExample)
|
2008-08-18 |
2018-03-31 |
|
|
|
KR20110051245A
(ko)
|
2008-09-10 |
2011-05-17 |
제넨테크, 인크. |
안구 혈관신생의 억제 방법
|
|
NZ592338A
(en)
|
2008-09-26 |
2012-11-30 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
GB0819449D0
(en)
|
2008-10-23 |
2008-12-03 |
Cambridge Display Tech Ltd |
Display drivers
|
|
CA2742968C
(en)
|
2008-11-07 |
2020-06-09 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
EP3061808B1
(en)
|
2009-02-03 |
2020-08-12 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising said stem cells
|
|
US20100254979A1
(en)
|
2009-03-06 |
2010-10-07 |
Cisthera, Incorporated |
Humanized PAI-1 Antibodies and Uses Thereof
|
|
EP2424567B1
(en)
|
2009-04-27 |
2018-11-21 |
OncoMed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
WO2011038290A2
(en)
|
2009-09-25 |
2011-03-31 |
The U. S. A., As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to hiv-1 and their use
|
|
EP2486126B1
(en)
|
2009-10-06 |
2017-12-06 |
SNU R & DB Foundation |
Method for differentiation into retinal cells from stem cells
|
|
SI2519543T1
(sl)
|
2009-12-29 |
2016-08-31 |
Emergent Product Development Seattle, Llc |
Beljakovine, ki se vežejo s heterodimeri in njihova uporaba
|
|
US20140148348A1
(en)
|
2010-01-13 |
2014-05-29 |
Christine Kuslich |
Dectection of gastrointestinal disorders
|
|
AU2011217964B2
(en)
|
2010-02-19 |
2016-07-14 |
The Board Of Regents Of The University Of Oklahoma |
Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
|
|
KR101899835B1
(ko)
|
2010-03-24 |
2018-09-19 |
제넨테크, 인크. |
항-ｌｒｐ６ 항체
|
|
AU2011235904B2
(en)
|
2010-04-01 |
2015-10-08 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
WO2011127164A2
(en)
|
2010-04-08 |
2011-10-13 |
Fate Therapeutics, Inc. |
Pharmaceutical compositions to treat fibrosis
|
|
ES2949159T3
(es)
|
2010-05-06 |
2023-09-26 |
Novartis Ag |
Composiciones y métodos de uso para anticuerpos terapéuticos de proteína 6 relacionada con lipoproteínas de baja densidad (LRP6)
|
|
BR112012028326A2
(pt)
|
2010-05-06 |
2017-03-21 |
Novartis Ag |
anticorpo multivalente isolado, anticorpos biparatópicos isolados, ácido nucleico, vetor, composição farmacêutica, método de obtenção dos referidos anticorpos, bem como uso do dos mesmos
|
|
RU2604490C2
(ru)
|
2010-11-05 |
2016-12-10 |
Займворкс Инк. |
ДИЗАЙН УСТОЙЧИВОГО ГЕТЕРОДИМЕРНОГО АНТИТЕЛА С МУТАЦИЯМИ В Fc ДОМЕНЕ
|
|
CA2825211A1
(en)
|
2011-01-28 |
2012-08-02 |
The Board Of Trustees Of The Leland Standford Junior University |
Wnt compositions and methods of use thereof
|
|
GB201106395D0
(en)
|
2011-04-14 |
2011-06-01 |
Hubrecht Inst |
Compounds
|
|
US9102724B2
(en)
|
2011-08-12 |
2015-08-11 |
Omeros Corporation |
Anti-FZD10 monoclonal antibodies and methods for their use
|
|
JP2014527818A
(ja)
*
|
2011-09-16 |
2014-10-23 |
フェイト セラピューティクス，インコーポレイテッド |
Ｗｎｔ組成物およびそのような組成物の治療的使用
|
|
ES2769786T3
(es)
|
2011-10-14 |
2020-06-29 |
Recordati Ag |
Anticuerpos y métodos para enfermedades relacionadas con la vía Wnt
|
|
JP2015502741A
(ja)
|
2011-11-04 |
2015-01-29 |
ノバルティス アーゲー |
低比重リポタンパク質関連タンパク質６（ｌｒｐ６）−半減期延長構築物
|
|
CN104203981A
(zh)
|
2011-12-19 |
2014-12-10 |
合成免疫股份有限公司 |
双特异性抗体分子
|
|
IN2014DN05885A
(enExample)
|
2012-01-18 |
2015-06-05 |
Hoffmann La Roche |
|
|
WO2014029752A1
(en)
|
2012-08-22 |
2014-02-27 |
Glaxo Group Limited |
Anti lrp6 antibodies
|
|
WO2014059068A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Methods for the treatment and prevention of osteoporosis and bone-related disorders
|
|
JP6324974B2
(ja)
|
2012-10-12 |
2018-05-23 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
タウの毒性オリゴマー形態を特異的に認識する抗体ベースの試薬
|
|
US9359444B2
(en)
|
2013-02-04 |
2016-06-07 |
Oncomed Pharmaceuticals Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
|
WO2014124326A1
(en)
|
2013-02-08 |
2014-08-14 |
Stem Centrx, Inc. |
Novel multispecific constructs
|
|
WO2014130728A1
(en)
|
2013-02-21 |
2014-08-28 |
Van Andel Research Institute |
Norrin mutant polypeptides, methods of making and uses thereof
|
|
US20140255403A1
(en)
|
2013-03-06 |
2014-09-11 |
Hadasit Medical Research Services & Development Ltd. |
Oral composition comprising a tnf antagonist and use thereof
|
|
RU2015131718A
(ru)
|
2013-03-14 |
2017-04-19 |
Онкомед Фармасьютикалс, Инк. |
Мет-связывающие агенты и их применения
|
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
|
SG11201507416WA
(en)
|
2013-03-15 |
2015-10-29 |
Amgen Inc |
Human pac1 antibodies
|
|
US20160022769A1
(en)
|
2013-03-15 |
2016-01-28 |
Retinal Solutions Llc |
Compostions and methods for treating retinal disease
|
|
EP3033356B1
(en)
|
2013-08-14 |
2020-01-15 |
Sachdev Sidhu |
Antibodies against frizzled proteins and methods of use thereof
|
|
GB2518221A
(en)
|
2013-09-16 |
2015-03-18 |
Sergej Michailovic Kiprijanov |
Tetravalent antigen-binding protein molecule
|
|
MX2016003617A
(es)
|
2013-09-30 |
2016-07-21 |
Chugai Pharmaceutical Co Ltd |
Metodo para producir molecula de enlace al antigeno usando fago auxiliar modificado.
|
|
GB2519786A
(en)
|
2013-10-30 |
2015-05-06 |
Sergej Michailovic Kiprijanov |
Multivalent antigen-binding protein molecules
|
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|
|
WO2015109212A1
(en)
*
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
US20170240631A1
(en)
|
2014-08-08 |
2017-08-24 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
KR102493376B1
(ko)
|
2014-09-03 |
2023-01-27 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법
|
|
US11142577B2
(en)
|
2014-09-12 |
2021-10-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
WNT signaling agonist molecules
|
|
RS60615B1
(sr)
|
2014-11-20 |
2020-08-31 |
Hoffmann La Roche |
Zajednički laki lanci i postupci upotrebe
|
|
US9777052B2
(en)
|
2014-12-02 |
2017-10-03 |
The Board Of Regents Of The University Of Oklahoma |
R-spondin variants, compositions, and methods of use
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016168607A1
(en)
|
2015-04-15 |
2016-10-20 |
University Of Tennessee Research Foundation |
Compositions and methods of muc13 antibodies for cancer treatment and diagnosis
|
|
US20160312207A1
(en)
|
2015-04-21 |
2016-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
R-spondin antagonists and methods of treating cancer associated with aberrant activation of wnt signaling
|
|
WO2016205566A1
(en)
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
US10766962B2
(en)
|
2015-06-16 |
2020-09-08 |
The Regents Of The University Of California |
FZD7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
AU2016341982B2
(en)
|
2015-10-21 |
2022-07-07 |
Indiana University Research And Technology Corporation |
Methods of generating human inner ear sensory epithelia and sensory neurons
|
|
AR106949A1
(es)
|
2015-12-04 |
2018-03-07 |
Boehringer Ingelheim Int |
Polipéptidos biparatópicos que antagonizan la señalización wnt en células tumorales
|
|
WO2017127933A1
(en)
|
2016-01-29 |
2017-08-03 |
The Governing Council Of The University Of Toronto |
Frizzled protein-binding agents and methods of use thereof
|
|
IL313507A
(en)
|
2016-02-03 |
2024-08-01 |
Amgen Res Munich Gmbh |
Constructs of bispecific antibodies to BCMA and CD3 that bind to T cells, preparations containing the same and uses thereof
|
|
NZ743881A
(en)
|
2016-02-06 |
2023-11-24 |
Epimab Biotherapeutics Inc |
Fabs-in-tandem immunoglobulin and uses thereof
|
|
WO2017151907A1
(en)
|
2016-03-02 |
2017-09-08 |
Frequency Therapeutics, Inc. |
Methods for controlled proliferation of stem cells / generating inner ear hair cells using gsk-3-alpha inhibitors
|
|
US11472877B2
(en)
|
2016-03-04 |
2022-10-18 |
Alector Llc |
Anti-TREM1 antibodies and methods of use thereof
|
|
US20170349659A1
(en)
|
2016-06-03 |
2017-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt signaling agonist molecules
|
|
CA3049661A1
(en)
|
2017-01-11 |
2018-07-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
R-spondin (rspo) surrogate molecules
|
|
CN110234662A
(zh)
|
2017-01-26 |
2019-09-13 |
瑟罗泽恩公司 |
组织特异性wnt信号增强分子和其用途
|
|
KR102717656B1
(ko)
|
2017-05-31 |
2024-10-14 |
베링거 인겔하임 인터내셔날 게엠베하 |
종양 세포에서 wnt 신호 전달을 길항하는 폴리펩티드
|
|
EP3708589A4
(en)
|
2017-11-08 |
2021-08-11 |
Kyowa Kirin Co., Ltd. |
BISPECIFIC ANTIBODIES THAT BIND TO CD40 AND EpCAM
|
|
JP7418332B2
(ja)
|
2017-12-19 |
2024-01-19 |
スロゼン オペレーティング， インコーポレイテッド |
抗フリズルド抗体及び使用方法
|
|
CN118271444A
(zh)
|
2017-12-19 |
2024-07-02 |
瑟罗泽恩奥普瑞汀公司 |
Wnt替代分子和其用途
|
|
US11746150B2
(en)
|
2017-12-19 |
2023-09-05 |
Surrozen Operating, Inc. |
Anti-LRP5/6 antibodies and methods of use
|
|
WO2019159084A1
(en)
|
2018-02-14 |
2019-08-22 |
Angers Stephane |
Multivalent binding molecules activating wnt signaling and uses thereof
|
|
EP3768701B1
(en)
|
2018-03-23 |
2023-08-02 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules
|
|
DK3820906T3
(da)
|
2018-07-05 |
2025-12-15 |
Surrozen Operating Inc |
Multispecifikke wnt-surrogatmolekyler og anvendelser deraf
|
|
EP3820499A4
(en)
|
2018-07-09 |
2022-07-13 |
Surrozen Operating, Inc. |
TISSUE SPECIFIC WNT SIGNAL ENHANCEMENT MOLECULES AND USES
|
|
WO2020018445A1
(en)
|
2018-07-16 |
2020-01-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Frizzled specific wnt agonists and antagonists
|
|
WO2020132356A1
(en)
|
2018-12-19 |
2020-06-25 |
Surrozen, Inc. |
Antigen binding formats for receptor complexes
|
|
CA3129155A1
(en)
|
2019-02-11 |
2020-08-20 |
Surrozen, Inc. |
Modulation of wnt signalling in ocular disorders
|
|
US20220195053A1
(en)
|
2019-03-11 |
2022-06-23 |
Surrozen Operating Inc. |
Modulation of wnt signaling in gastrointestinal disorders
|
|
US20220175884A1
(en)
|
2019-04-02 |
2022-06-09 |
Surrozen Operating, Inc. |
Modulation of wnt signaling in auditory disorders
|
|
US11050604B2
(en)
|
2019-07-01 |
2021-06-29 |
Rampart Communications, Inc. |
Systems, methods and apparatuses for modulation-agnostic unitary braid division multiplexing signal transformation
|
|
AU2020300618A1
(en)
|
2019-07-02 |
2022-01-27 |
Surrozen Operating, Inc. |
Monospecific anti-frizzled antibodies and methods of use
|
|
CN115427446A
(zh)
|
2020-02-24 |
2022-12-02 |
瑟罗泽恩奥普瑞汀公司 |
Wnt超级激动剂
|
|
EP4110465A4
(en)
|
2020-02-24 |
2024-06-12 |
The Board Of Regents Of The University Of Texas System |
MOLECULAR BIOMARKERS AND TARGETS FOR FUCHS ENDOTHELIAL CORNEAL DYSTROPHY AND GLAUCOMA
|
|
TW202233656A
(zh)
|
2020-11-16 |
2022-09-01 |
美商蘇羅森營運公司 |
肝特異性wnt訊號增強分子及其用途
|
|
AU2021399278A1
(en)
|
2020-12-18 |
2023-06-29 |
Antlera Therapeutics Inc. |
Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof
|
|
AU2022232380A1
(en)
|
2021-03-10 |
2023-09-21 |
Surrozen Operating, Inc. |
Modulation of wnt signaling in gastrointestinal disorders
|
|
EP4277509A1
(en)
|
2021-07-20 |
2023-11-22 |
Boston Scientific Medical Device Limited |
Over the scope clip with repositional capability
|
|
CA3229303A1
(en)
|
2021-09-14 |
2023-03-23 |
Russell FLETCHER |
Modulation of wnt signalling in pulmonary disorders
|
|
EP4448009A4
(en)
|
2021-12-17 |
2025-12-10 |
Surrozen Operating Inc |
WNT SUBSTITUTION AGENTS AND LACRYMAL GLAND REGENERATION METHODS
|
|
KR20240126877A
(ko)
*
|
2021-12-31 |
2024-08-21 |
서로젠 오퍼레이팅, 인크. |
Wnt 수용체 특이적 화합물 및 이와 관련된 방법
|
|
JP2025525362A
(ja)
|
2022-06-21 |
2025-08-05 |
スロゼン オペレーティング， インコーポレイテッド |
角膜障害におけるｗｎｔシグナル伝達の調節
|
|
WO2024040118A2
(en)
|
2022-08-16 |
2024-02-22 |
Surrozen Operating, Inc. |
Cell targeting multicomponent polypeptide
|
|
US20240262918A1
(en)
|
2022-12-30 |
2024-08-08 |
Surrozen Operating, Inc. |
Fc-modified wnt surrogate molecules and uses thereof
|
|
WO2024249444A2
(en)
|
2023-05-29 |
2024-12-05 |
Surrozen Operating, Inc. |
Wnt surrogate agents and methods for lacrimal gland regeneration
|